Search for the latest updates on diabetes
News
Poxel's Investigational Oral Agent - Imeglimin - Shows Unique Anti-diabetic Profile in Preclinical and Clinical Studies Stock World - 31 minutes
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment